Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. J. Pers. Med. 2022, 12, 555”

Hao Wei Kou; Jun Te Hsu

doi:10.3390/jpm12071069

Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. J. Pers. Med. 2022, 12, 555”

Hao Wei Kou, Jun Te Hsu^*

^*Corresponding author for this work

School of Medicine

Chang Gung University

Research output: Contribution to journal › Comment/debate

Original language	English
Article number	1069
Journal	Journal of Personalized Medicine
Volume	12
Issue number	7
DOIs	https://doi.org/10.3390/jpm12071069
State	Published - 07 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/jpm12071069

Cite this

Kou, H. W., & Hsu, J. T. (2022). Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. J. Pers. Med. 2022, 12, 555”. Journal of Personalized Medicine, 12(7), Article 1069. https://doi.org/10.3390/jpm12071069

@article{89c25a129d1844cb8bfa741381c0ac21,

title = "Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. J. Pers. Med. 2022, 12, 555”",

author = "Kou, {Hao Wei} and Hsu, {Jun Te}",

year = "2022",

month = jul,

doi = "10.3390/jpm12071069",

language = "英语",

volume = "12",

journal = "Journal of Personalized Medicine",

issn = "2075-4426",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "7",

}

Kou, HW & Hsu, JT 2022, 'Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. J. Pers. Med. 2022, 12, 555”', Journal of Personalized Medicine, vol. 12, no. 7, 1069. https://doi.org/10.3390/jpm12071069

Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. J. Pers. Med. 2022, 12, 555”. / Kou, Hao Wei; Hsu, Jun Te.
In: Journal of Personalized Medicine, Vol. 12, No. 7, 1069, 07.2022.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. J. Pers. Med. 2022, 12, 555”

AU - Kou, Hao Wei

AU - Hsu, Jun Te

PY - 2022/7

Y1 - 2022/7

UR - http://www.scopus.com/inward/record.url?scp=85134466002&partnerID=8YFLogxK

U2 - 10.3390/jpm12071069

DO - 10.3390/jpm12071069

M3 - 评论/辩论

AN - SCOPUS:85134466002

SN - 2075-4426

VL - 12

JO - Journal of Personalized Medicine

JF - Journal of Personalized Medicine

IS - 7

M1 - 1069

ER -

Kou HW, Hsu JT. Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. J. Pers. Med. 2022, 12, 555”. Journal of Personalized Medicine. 2022 Jul;12(7):1069. doi: 10.3390/jpm12071069

Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on “Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. J. Pers. Med. 2022, 12, 555”

UN SDGs

Access to Document

Other files and links

Cite this